Briggs Morrison - 14 Jan 2022 Form 4 Insider Report for ARVINAS, INC. (ARVN)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
19 Jan 2022, 20:00:12 UTC
Prior SEC filing
20 Dec 2021
Next SEC filing
03 Feb 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Matthew Batters, as attorney-in-fact for Briggs Morrison

Key filing fact

Briggs Morrison filed Form 4 for ARVINAS, INC. (ARVN) on 19 Jan 2022.

Key facts

  • This page summarizes Briggs Morrison's Form 4 filing for ARVINAS, INC. (ARVN).
  • 6 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 19 Jan 2022, 20:00.

Change

  • Previous filing in this sequence was filed on 20 Dec 2021.
  • Current net transaction value: -$1,115,013.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ARVN transaction

Common Stock

Options Exercise

Transaction value
$259,008
Shares
+16,188
Change %
+55%
Price
$16.00
Shares after
45,708
Date
14 Jan 2022
Ownership
Direct
Footnotes
F1
ARVN transaction

Common Stock

Sale

Transaction value
$638,109
Shares
-9,919
Change %
-22%
Price
$64.33
Shares after
35,789
Date
14 Jan 2022
Ownership
Direct
Footnotes
F1, F2
ARVN transaction

Common Stock

Sale

Transaction value
$250,071
Shares
-3,833
Change %
-11%
Price
$65.24
Shares after
31,956
Date
14 Jan 2022
Ownership
Direct
Footnotes
F1, F3
ARVN transaction

Common Stock

Sale

Transaction value
$343,144
Shares
-5,100
Change %
-16%
Price
$67.28
Shares after
26,856
Date
14 Jan 2022
Ownership
Direct
Footnotes
F1, F4
ARVN transaction

Common Stock

Sale

Transaction value
$142,696
Shares
-2,108
Change %
-7.8%
Price
$67.69
Shares after
24,748
Date
14 Jan 2022
Ownership
Direct
Footnotes
F1, F5

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ARVN transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-16,188
Change %
-49%
Price
$0.000000
Shares after
16,682
Date
14 Jan 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
16,188
Exercise price
$16.00
Footnotes
F1, F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

The exercises and sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2021.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.9000 to $64.8800, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2).

Footnote F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.9200 to $65.8900, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the SEC, upon request, the number of shares sold at each separate price within the range set forth in this footnote (3).

Footnote F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.5300 to $67.5200, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the SEC, upon request, the number of shares sold at each separate price within the range set forth in this footnote (4).

Footnote F5

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.5400 to $67.9600, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer or the Staff of the SEC, upon request, the number of shares sold at each separate price within the range set forth in this footnote (5).

Footnote F6

This option award was granted on September 26, 2018. 1/12 of the shares underlying the award vested as of June 28, 2018, with the remainder of the shares vesting in equal quarterly installments following June 28, 207 through March 28, 2021.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .